Virtu Financial’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Virtu Financial’s Portfolio NVOS Stock Details NVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-40,535	Closed	-$11K	–	2281
2024 Q3	$11K	Sell	40,535 -35,917	-47%	-$16.8K	﹤0.01%	1196
2024 Q2	$57K	Buy	76,452 +14,388	+23%	+$9.21K	﹤0.01%	889
2024 Q1	$30K	Sell	62,064 -24,133	-28%	-$16.2K	﹤0.01%	1111
2023 Q4	$71K	Buy	+86,197	New	+$175K	0.01%	1110
2023 Q3	–	Sell	-23,348	Closed	-$35K	–	2147
2023 Q2	$35K	Buy	23,348 +10,271	+79%	+$14K	﹤0.01%	1180
2023 Q1	$16K	Buy	+13,077	New	+$17.4K	﹤0.01%	1296

Other funds holding NVOS

ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

Virtu Financial's NVOS Position: Q4 2024 in Review

Virtu Financial sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2024, closing a stake of 40,535 shares — an estimated $11K sold.

Virtu Financial first reported a position in NVOS in Q1 2023 and held it in 6 quarters. The position peaked at $71K in Q4 2023. 1 fund tracked by Wall St. Rank holds NVOS as of Q4 2024.

Virtu Financial reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Virtu Financial sold 40,535 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2024, an estimated $11K.
Virtu Financial first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q1 2023 and held it in 6 quarters.
Virtu Financial's Novo Integrated Sciences, Inc. Common Stock position peaked at $71K in Q4 2023.
1 fund tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.